Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tissue Niche Miniature of Glioblastoma Patient Treated with Nano‐Awakeners to Induce Suicide of Cancer Stem Cells

1 Sept 2022

Abstract excerpt

Patient-specific cancer therapies can evolve by vitalizing the mother tissue-like cancer niche, cellular profile, genetic signature, and drug responsiveness. This evolution has enabled the elucidation of a key mechanism along with development of the mechanism-driven therapy. After surgical treatment, glioblastoma (GBM) patients require prompt therapy within 14 days in a patient-specific manner. Hence, this study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3D Printing in Biomedical Research
Share to Cancer Cells and Metastasis
Share to Extracellular vesicles in disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36047642
DOI: 10.1002/adhm.202201586

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tissue Niche Miniature of Glioblastoma Patient Treated with Nano‐Awakeners to Induce Suicide of Cancer Stem CellsPMID 36047642Read ↗

<i>On-chip</i> perivascular niche with patient-derived glioma cellsSemantic proximity Read ↗

Blood-tumor barrier organoids recapitulate glioblastoma microenvironment and enable high-throughput modeling of therapeutic deliverySemantic proximity Read ↗

Tumoroid-on-a-Plate (ToP): Physiologically Relevant Cancer Model Generation and Therapeutic ScreeningSemantic proximity Read ↗

Nanomedicines Targeting Glioma Stem CellsSemantic proximity Read ↗

<i>Ex vivo</i> dynamics of human glioblastoma cells in a microvasculature-on-a-chip system correlates with tumor heterogeneity and subtypesSemantic proximity Read ↗

Advancing Glioblastoma Research with Innovative Brain Organoid-Based ModelsSemantic proximity Read ↗

Tumor microenvironment complexity and therapeutic implications at a glanceSemantic proximity Read ↗

Drug screening model meets cancer organoid technologySemantic proximity Read ↗

Multi-Cell Type Glioblastoma Tumor Spheroids for Evaluating Sub-Population-Specific Drug ResponseSemantic proximity Read ↗

Understanding proneural–mesenchymal transition using patient-derived glioma stem-like cell (GSC) organoids and engineered extracellular matrixSemantic proximity Read ↗

Modeling Patient-Derived Glioblastoma with Cerebral OrganoidsSemantic proximity Read ↗

Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.